Table 3.

The comorbidities of the patients in the three study groups

	ICI patients N = 53	CT patients N = 55	NoC patients N = 53
Dermatological tumours	23 (43%)	0 (0%)	–
Thoracic tumours	20 (38%)	21 (38%)	–
Gastrointestinal tumours	2 (4%)	27 (49%)	–
Other tumours	8 (15%)	7 (13%)	–
Cardiovascular diseases	–	–	26 (49%)
Gynaecological diseases	–	–	12 (23%)
Other non-oncological diseases	–	–	15 (28%)
Metastasis	51 (96%)	47 (85%)	–
Experience with CT	26 (49%)	55 (100%)	0 (0%)
ICI therapy
PD-1 inhibitors	43 (81%)	–	–
Other	10 (19%)	–	–